The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan

References

• Cheng MF, Yu KW, Tang RB, . Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 2004; 48: 33–37.
   PubMedGoogle Scholar
• Pfaller MA, Jones RN, Doern GV, . Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–751.
   PubMed Web of Science ®Google Scholar
• Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 2004; 25: 60–64.
   PubMed Web of Science ®Google Scholar
• Edwards EJJ. Candida species. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases 4th. New York: Churchill Livingstone Inc, 1995: 2289–2306.
   Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Warnock DW. Trends in the epidemiology of invasive fungal infections. Nippon Ishinkin Gakkai Zasshi 2007; 48: 1–12.
   PubMedGoogle Scholar
• Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32: 975–980.
   PubMed Web of Science ®Google Scholar
• Cheng MF, Yang YL, Yao TJ, . Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 2005; 5: 22.
   PubMedGoogle Scholar
• Peman J, Canton E, Gobernado M. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005; 24: 23–30.
   PubMed Web of Science ®Google Scholar
• Yang YL, Li SY, Cheng HH, Lo HJ. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis 2005; 5: 99–
   PubMedGoogle Scholar
• Yang YL, Wang AH, Wang CW, . Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn Microbiol Infect Dis 2008; 61: 175–180.
   PubMedGoogle Scholar
• Lo HJ, Ho AH, Ho M. Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect 2001; 34: 171–177.
   PubMedGoogle Scholar
• Larone DH. Laboratory procedures. Larone DH. Medically Important Fungi: A Guide to Identification, 3rd. New York: ASM Press, 1995: 209–223.
   Google Scholar
• Leaw SN, Chang HC, Barton R, Bouchara JP, Chang TC. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J Clin Microbiol 2007; 45: 2220–2229.
   PubMedGoogle Scholar
• Leaw SN, Chang HC, Sun HF, . Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006; 44: 693–699.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27A, Wayne, PA, 1997.
   Google Scholar
• Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 2004; 53: 217–224.
   PubMedGoogle Scholar
• Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, . Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 2002; 46: 2477–2481.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Brueggemann AB, . Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40: 1298–1302.
   PubMed Web of Science ®Google Scholar
• Chai YA, Wang Y, Khoo AL, . Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital. Med Mycol 2007; 45: 435–439.
   PubMed Web of Science ®Google Scholar
• Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007; 35: 256–259.
   PubMed Web of Science ®Google Scholar
• Voss A, Kluytmans JA, Koeleman JG, . Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909–912.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Lee LN, Jerng JS, Yu CJ, Hsueh PR. Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect 2008; 14: 136–140.
   PubMedGoogle Scholar
• Tuon FF, de Almeida GM, Costa SF. Central venous catheter-associated fungemia due to Rhodotorula spp. – a systematic review. Med Mycol 2007; 45: 441–447.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243–260.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 2003; 41: 1440–1446.
   PubMed Web of Science ®Google Scholar
• Cheng S, Clancy CJ, Nguyen KT, Clapp W, Nguyen MH. A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Antimicrob Agents Chemother 2007; 51: 1855–1858.
   PubMedGoogle Scholar
• Yang YL, Cheng MF, Chang YW, . Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed 2008; 7: 12–
   PubMedGoogle Scholar
• Kontoyiannis DP. Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis. Clin Infect Dis 2002; 34: 1281–1283.
   PubMedGoogle Scholar
• Ostrosky-Zeichner L, Rex JH, Pfaller MA, . Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother 2008; 52: 4175–4177.
   PubMed Web of Science ®Google Scholar
• Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect 2003; 36: 187–191.
   PubMedGoogle Scholar
• Yang YL, Li SY, Cheng HH, Lo HJ. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis 2005; 51: 179–183.
   PubMed Web of Science ®Google Scholar
• Tavanti A, Davidson AD, Johnson EM, . Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol 2005; 43: 5593–5600.
   PubMed Web of Science ®Google Scholar
• Chou HH, Lo HJ, Chen KW, Liao MH, Li SY. Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis 2007; 58: 427–433.
   PubMedGoogle Scholar
• Wang JS, Li SY, Yang YL, Chou HH, Lo HJ. Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. J Med Microbiol 2007; 56: 650–653.
   PubMedGoogle Scholar
• Li SY, Yang YL, Lin YH, . Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006. Microb Drug Resist 2009; in press.
   PubMedGoogle Scholar